Listed

Emergent BioSolutions Inc.: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 5, 2017 and accepted by EDGAR at May 4, 2017, 18:09 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-01-01 to 2017-03-31$46.3mus-gaap:CostOfGoodsSold
Research and development3 months2017-01-01 to 2017-03-31$20.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-01-01 to 2017-03-31$35.1mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-01-01 to 2017-03-31$14.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-01-01 to 2017-03-31$1.9mus-gaap:InterestExpense
Income tax3 months2017-01-01 to 2017-03-31$3.2mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-01-01 to 2017-03-31$10.5mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-01-01 to 2017-03-31$0.23us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-01-01 to 2017-03-31$0.26us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-01-01 to 2017-03-3149,718,426 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure3 months2017-01-01 to 2017-03-31$20.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2017-01-01 to 2017-03-31$81.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-03-31$270.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$489.2mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$951.6mus-gaap:Assets
Current liabilitiesAt period end2017-03-31$67.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$341.2mus-gaap:Liabilities
Long-term debtAt period end2017-03-31$248.4mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2017-03-31$610.4mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001367644-17-000022. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.